WILSON TROY EDWARD sold RNA
September 5, 2025 · Form 4 insider transaction
WILSON TROY EDWARD sold 15,000 shares of Atrium Therapeutics, Inc. at $50.00 per share, a transaction worth $750.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
15,000
Price
$50.00
Total value
$750.0K
InsiderWILSON TROY EDWARD
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 5, 2025
Filing dateSeptember 9, 2025
Shares owned after54,425
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
All exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on December 4, 2024.